SynthesisJournal of human hypertension2026
Prevalence and trends of hypertension among South Asian adults: a systematic review and meta-analysis.
Synthesis in Journal of human hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension, a major contributor to global cardiovascular disease related deaths, has seen a rise in low- and middle-income countries, especially in South Asia (SA) where ongoing demographic and lifestyle transitions are constantly elevating the cardiometabolic risk. We aimed to generate policy-relevant region-specific estimates of hypertension prevalence and temporal trends in SA in the past 25 years. A comprehensive systematic search of online databases (PubMed, Web of Science, Scopus), WHO STEPS surveys, and demographic and health surveys were conducted. Of 11 773 journal articles and 50 reports identified, 33 articles and 25 reports met inclusion criteria after screening by two independent reviewers. The pooled prevalence of hypertension in SA has increased from 24.6% (95%CI 18.5-30.6) in 2000-04 to 26.0% (95%CI 20.3-31.7) in 2020-25. According to the latest data, Pakistan reports the highest (46.2%, 95%CI 45.2-47.2), while Bangladesh reports the lowest (20.4%, 95%CI 19.8-21.1) prevalence of the region. Hypertension prevalence has risen in most countries in SA in the past two decades, with Sri Lanka witnessing the steepest rise. Although hypertension has historically been more prevalent in urban populations, rural prevalence has seen a sharp rise over the years, likely linked to rapid urbanization. Nearly 1.3 billion adults in SA (37.5%; 95%CI 30.4-44.5) are pre-hypertensive. The region demonstrated a high Hypertension Epidemicity Index of 60.1%, indicating a substantial epidemic potential in the future, highlighting the need for urgent translation of existing policies into effective implementation to mitigate growing cardiovascular burden.
Indexed as
Identifiers
42426169What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.